Click HERE to download the PDF version

2013 is a year of remarkable milestones for Nitto Denko Avecia, the oligonucleotide contract manufacturing organizations (CMOs) industry leader. With its first outsourced program initiated in 1993, the company is celebrating 20 years of providing oligonucleotide development and manufacture services to the biotech and pharma markets. Throughout its evolution from UK based ICI and Zeneca, to its establishment of a US headquarters and its subsequent sale to Nitto Denko in 2011, Avecia has firmly established itself as a leader in oligonucleotide service, expertise, and delivery.

OliGROW: SMALL SCALE OLIGO PRODUCTION!
Avecia is pleased to unveil OliGROW, its new small scale oligonucleotide service designed to supplement the company’s existing large scale production capabilities. OliGROW applies Avecia’s expertise in oligonucleotide manufacture, and ...